selected publications
- Predicting outcomes in female germ cell tumors using a modified International Germ Cell Cancer Collaborative Group classification system to guide management. Gynecologic oncology. 2023 Academic Article GET IT
-
Ovarian cancer mutational processes drive site-specific immune evasion.
Nature.
2022
Academic Article
GET IT
Times cited: 45 - Genetic Ancestry Correlates with Somatic Differences in a Real-World Clinical Cancer Sequencing Cohort. Cancer discovery. 2022 Academic Article GET IT
-
MAPK Pathway Genetic Alterations Are Associated with Prolonged Overall Survival in Low-Grade Serous Ovarian Carcinoma.
Clinical cancer research : an official journal of the American Association for Cancer Research.
2022
Academic Article
GET IT
Times cited: 28 - Microsatellite Instability-High Endometrial Cancers with MLH1 Promoter Hypermethylation Have Distinct Molecular and Clinical Profiles. Clinical cancer research : an official journal of the American Association for Cancer Research. 2022 Academic Article GET IT
- Germline SMARCA4 Deletion as a Driver of Uterine Cancer: An Atypical Presentation. 2022 GET IT
-
Gene-based Confirmatory Germline Testing Following Tumor-only Sequencing of Prostate Cancer.
European urology.
2022
Academic Article
GET IT
Times cited: 1 - Disparities in cancer genetics care by race/ethnicity among pan-cancer patients with pathogenic germline variants. Cancer. 2022 Academic Article GET IT
- Treatment of ovarian clear cell carcinoma with immune checkpoint blockade: a case series. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society. 2022 Academic Article GET IT
-
Olaparib treatment for platinum-sensitive relapsed ovarian cancer by BRCA mutation and homologous recombination deficiency status: Phase II LIGHT study primary analysis.
Gynecologic oncology.
2022
Academic Article
GET IT
Times cited: 1 -
Multimodal data integration using machine learning improves risk stratification of high-grade serous ovarian cancer.
Nature cancer.
2022
Academic Article
GET IT
Times cited: 72 -
BMP2/SMAD pathway activation in JAK2/p53-mutant megakaryocyte/erythroid progenitors promotes leukemic transformation.
Blood.
2022
Academic Article
GET IT
Times cited: 1 - Germline Pathogenic Variants Impact Clinicopathology of Advanced Lung Cancer. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 2022 Academic Article GET IT
- Abnormal B-lymphoblasts in myelodysplastic syndromes and myeloproliferative neoplasms other than chronic myeloid leukemia. Cytometry. Part B, Clinical cytometry. 2022 Academic Article GET IT
-
Gastric-type adenocarcinoma of the cervix in patients with Peutz-Jeghers syndrome: a systematic review of the literature with proposed screening guidelines.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society.
2022
Academic Article
GET IT
Times cited: 2 - Early age of onset and broad cancer spectrum persist in MSH6- and PMS2-associated Lynch syndrome. Genetics in medicine : official journal of the American College of Medical Genetics. 2022 Academic Article GET IT
-
Comprehensive assessment of germline pathogenic variant detection in tumor-only sequencing.
Annals of oncology : official journal of the European Society for Medical Oncology.
2022
Academic Article
GET IT
Times cited: 19 - Geometric network analysis provides prognostic information in patients with high grade serous carcinoma of the ovary treated with immune checkpoint inhibitors. NPJ genomic medicine. 2021 Academic Article GET IT
-
TP53 Combined Phenotype Score Is Associated with the Clinical Outcome of TP53-Mutated Myelodysplastic Syndromes.
Cancers.
2021
Academic Article
GET IT
Times cited: 2 -
Baseline risk of hematologic malignancy at initiation of frontline PARP inhibitor maintenance for BRCA1/2-associated ovarian cancer.
2021
GET IT
Times cited: 3 -
Diagnosis and management of an endometrial cancer patient with Cowden syndrome.
2021
GET IT
Times cited: 1 -
Tetrathiomolybdate (TM)-associated copper depletion influences collagen remodeling and immune response in the pre-metastatic niche of breast cancer.
NPJ breast cancer.
2021
Academic Article
GET IT
Times cited: 33 -
The Future of Parallel Tumor and Germline Genetic Testing: Is There a Role for All Patients With Cancer?.
Journal of the National Comprehensive Cancer Network : JNCCN.
2021
Review
GET IT
Times cited: 3 -
Risk of venous thromboembolism in ovarian cancer patients receiving neoadjuvant chemotherapy.
Gynecologic oncology.
2021
Academic Article
GET IT
Times cited: 17 -
Enhanced specificity of clinical high-sensitivity tumor mutation profiling in cell-free DNA via paired normal sequencing using MSK-ACCESS.
Nature communications.
2021
Academic Article
GET IT
Times cited: 65 -
Therapeutic Implications of Germline Testing in Patients With Advanced Cancers.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
2021
Academic Article
GET IT
Times cited: 66 -
Achieving universal genetic assessment for women with ovarian cancer: Are we there yet? A systematic review and meta-analysis.
Gynecologic oncology.
2021
Information Resource
GET IT
Times cited: 37 -
Plasmacytoid dendritic cell expansion defines a distinct subset of RUNX1-mutated acute myeloid leukemia.
Blood.
2021
Academic Article
GET IT
Times cited: 51 -
Prevalence and Characterization of Biallelic and Monoallelic NTHL1 and MSH3 Variant Carriers From a Pan-Cancer Patient Population.
JCO precision oncology.
2021
Academic Article
GET IT
Times cited: 10 -
Routine Evaluation of Minimal Residual Disease in Myeloma Using Next-Generation Sequencing Clonality Testing: Feasibility, Challenges, and Direct Comparison with High-Sensitivity Flow Cytometry.
The Journal of molecular diagnostics : JMD.
2020
Academic Article
GET IT
Times cited: 16 -
Pre-operative neoadjuvant chemotherapy cycles and survival in newly diagnosed ovarian cancer: what is the optimal number? A Memorial Sloan Kettering Cancer Center Team Ovary study.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society.
2020
Academic Article
GET IT
Times cited: 22 -
FGFR1 Rearrangement Guides Diagnosis and Treatment of a Trilineage B, T, and Myeloid Mixed Phenotype Acute Leukemia.
2020
GET IT
Times cited: 2 -
RAS/MAPK Pathway Driver Alterations Are Significantly Associated With Oncogenic KIT Mutations in Germ-cell Tumors.
Urology.
2020
Academic Article
GET IT
Times cited: 5 -
BRCA Mutations, Homologous DNA Repair Deficiency, Tumor Mutational Burden, and Response to Immune Checkpoint Inhibition in Recurrent Ovarian Cancer.
JCO precision oncology.
2020
Academic Article
GET IT
Times cited: 28 -
Delays from neoadjuvant chemotherapy to interval debulking surgery and survival in ovarian cancer.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society.
2020
Academic Article
GET IT
Times cited: 7 -
Genetic Basis of Extramedullary Plasmablastic Transformation of Multiple Myeloma.
The American journal of surgical pathology.
2020
Academic Article
GET IT
Times cited: 20 -
Characteristics and survival of ovarian cancer patients treated with neoadjuvant chemotherapy but not undergoing interval debulking surgery.
Journal of gynecologic oncology.
2020
Academic Article
GET IT
Times cited: 20 -
Subsequent therapies and survival after immunotherapy in recurrent ovarian cancer.
Gynecologic oncology.
2019
Academic Article
GET IT
Times cited: 13 - The t(11;14)(q13;q32)/CCND1-IGH translocation in chronic lymphocytic leukaemia/small lymphocytic lymphoma: an unusual genetic aberration during the natural clinical course. Histopathology. 2019 Letter GET IT
- Transformation of monoclonal B lymphocytosis to Epstein-Barr virus-positive large B-cell lymphoma with intermediate features between diffuse large B-cell lymphoma and classic Hodgkin lymphoma. AJSP: reviews & reports. 2019 Academic Article GET IT
-
Combination Immune Checkpoint Blockade Strategies to Maximize Immune Response in Gynecological Cancers.
Current oncology reports.
2018
Information Resource
GET IT
Times cited: 37 -
Obesity's impact on survival is independent of dose adjustments in neoadjuvant chemotherapy in women with breast cancer.
Breast cancer research and treatment.
2017
Letter
GET IT
Times cited: 2